Product Code: RP-ID-10163646 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10163646
Market Overview:
Global Oral Anti-Diabetic Drugs Market: World Market Review and Analysis By Type, By Region, By Country: Opportunities and Forecast 2022-2030
"According to the report, the global organ transplant market is expected to witness significant growth during 2022-2030, expanding at a CAGR of ~8%. Drive the growth of the link search market. As the number of organ donors increases, transplant diagnosis is also expected to increase significantly.
Organ transplantation is a major advancement in modern medicine. Organ transplantation is a medical procedure in which an organ is removed from one body and transferred to another to replace the missing or damaged organ. One of the most important aspects of organ transplantation is to obtain the consent of the patient or the patient’s family. Organ harvesting without proper consent is illegal and a large-scale crime. Organ transplantation is mainly performed for brain-dead patients whose other organs are healthy and can be used to save the lives of others. The organ transplantation process should be performed immediately after the death of the patient and lasts up to several hours. This procedure is used to treat lung, liver, kidney and other organ failures. The kidney is the most transplanted organ, followed by the liver. Unfortunately, the demand for organ donors is far greater than the number of people who donate organs.
According to the National Kidney Foundation, more than 3,000 new patients are added to the kidney waiting list every month around the world. According to the Organ Sharing United Network, in the United States, 21 people die every day waiting for organs, and more than 120,000 men, women and children are waiting for life-saving organ transplants. Chronic diseases and organ failure. The increasing prevalence of kidney disease, excessive alcohol consumption and unhealthy diets are driving the growth of the organ transplant market. However, the high cost of transplantation, the limited number of donors, and the increasing incidence of organ failure have slowed the growth of the market.
Major players in the global organ transplantation market Novartis International AG (Switzerland), Terumo Medical Corporation (U.S.), Transonic (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Astellas Pharma, Inc (Japan), Preservation Solutions, Inc. (United States), OrganOX Limited (United Kingdom), Bio Med Pvt. Ltd. (United States), Transplant Biomedical (United Kingdom), TransMedic, Inc. (United States) , Accord Healthcare GmbH (Spain), Sanofi (France), Pfizer, Inc. (United States), Veloxis Pharmaceuticals A/S (Denmark), GlaxoSmithKline. (UK) Segmentation of the organ transplantation market The world organ transplantation market is subdivided into heart, kidney, liver, lung, etc. according to the type of organ. According to the products, they are divided into organ preservation solutions, transplant diagnosis, tissue products, etc. According to the type of transplantation, it is divided into autologous transplantation, allogeneic transplantation and allogeneic transplantation, xenotransplantation and xenotransplantation. On the basis of treatment, the market is divided into pain relievers and immunosuppressants. Immunosuppressants are further subdivided into calcineurin inhibitors, mTOR inhibitors, antiproliferative agents, steroids, etc. Calcineurin inhibitors are subdivided into tacrolimus and cyclosporine. mTOR inhibitors are subdivided into sirolimus and everolimus.
According to end users, the organ transplant market is segmented into hospitals, transplant centers, etc. Regional analysis Geographically, the organ transplant market is divided into the Americas, Europe, Asia Pacific, Middle East and Africa. The United States dominates the world organ transplant market. The increasing prevalence of organ failure, the rapid development of the medical industry, the development of the healthcare industry, and higher healthcare expenditures are the main driving forces for the growth of the US market. Europe is the second largest organ transplant market, followed by the Asia-Pacific region. The Asia-Pacific region is the fastest growing region in this market. The rapid development of economies and the existence of a large number of people suffering from chronic diseases are the main driving forces of the Asia-Pacific market.
In application, kidney transplantation is the most common organ transplantation in the world. Improving outcomes in patients with end-stage renal disease is very popular. Thanks to advances in kidney transplantation and the success rate of transplantation, many people consider kidney transplantation to be the best treatment for chronic kidney disease.
In recent years, the organ transplant market has grown significantly as a direct result of the increase in organ transplantation. In addition, high organ donation and chronic disease prevalence are expected to drive the market growth.
REPORT SCOPE :
Global Organ Transplant Market ACTUAL PERIOD: 2014-2021, FORECAST PERIOD: 2022- 2030 Liver, Kidney, Heart, etc.
REGIONAL ANALYSIS:
North America, Europe, Asia Pacific, ROW ACTUAL PERIOD: 2014-2021, FORECAST PERIOD: 2022- 2030-
Organ Transplant Market - Size, Growth, Product Type Forecast - Organ Transplants, Immunosuppressants and Other Diagnostic Objects: Kidney , liver, heart, etc.
COUNTRY ANALYSIS:
USA, Canada, Germany, France, UK, Italy, Spain, China, South Korea, India ACTUAL PERIOD: 2014-2021, FORECAST PERIOD: 2022- 20304):
Organ Transplant Market by Size, Growth, Product Prediction type - depending on product use for organ protection, transplant testing, immunosuppression, etc.: Kidney, Liver, Heart, etc."
Novartis, Pfizer, Sanofi, Merck & Co., AstraZeneca, Janssen Pharmaceutical, Boehringer Ingelheim, Eli Lilly, Takeda Pharmaceutical.
Related Reports
Proof of Quality & Reliability
